Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Access to Bispecific Therapies for Multiple Myeloma: An Overview of Barriers and Emerging Solutions.
Access to Bispecific Therapies for Multiple Myeloma: An Overview of Barriers and Emerging Solutions.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 09, 2026
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 27, 2024
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 09, 2024
Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer.
Journal: Scientific reports
Published: November 28, 2023
Ibrutinib-associated cutaneous mucormycosis due to an Apophysomyces species: report of a case and review of the literature.
Journal: Therapeutic advances in infectious disease
Published: September 26, 2023
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article.
Journal: Blood and lymphatic cancer : targets and therapy
Published: June 15, 2023
Pathophysiology and Treatments of Complications of Waldenström's Macroglobulinemia.
Journal: Clinical hematology international
Published: May 09, 2023
Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.
Journal: Cancer research communications
Published: February 27, 2023
Veterans with blood cancers: Clinical trial navigation and the challenge of rurality.
Journal: The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association
Published: October 25, 2022
Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series.
Journal: Clinical hematology international
Published: March 24, 2022
Last Updated: 09/26/2026